116 related articles for article (PubMed ID: 8588035)
1. European clinical experience with Endorem. A new contrast agent for liver MRI in 1000 patients.
Chachuat A; Bonnemain B
Radiologe; 1995 Nov; 35(11 Suppl 2):S274-6. PubMed ID: 8588035
[No Abstract] [Full Text] [Related]
2. Liver MR imaging with iron oxides: toward consensus and clinical practice.
Weissleder R
Radiology; 1994 Dec; 193(3):593-5. PubMed ID: 7972790
[No Abstract] [Full Text] [Related]
3. [The endorem tolerance profile].
Laniado M; Chachuat A
Radiologe; 1995 Nov; 35(11 Suppl 2):S266-70. PubMed ID: 8588033
[TBL] [Abstract][Full Text] [Related]
4. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
Pleger B; Beyer HK; Laufer U
Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
[No Abstract] [Full Text] [Related]
5. [Differential diagnosis of focal liver lesions with MRI using the superparamagnetic contrast medium endorem].
Vogl TJ; Hammerstingl R; Keck H; Felix R
Radiologe; 1995 Nov; 35(11 Suppl 2):S258-66. PubMed ID: 8588032
[TBL] [Abstract][Full Text] [Related]
6. [Obsolete methods in examination of the liver with MRI].
Schadmand-Fischer S
Rofo; 1998 Dec; 169(6):679-80. PubMed ID: 9930229
[No Abstract] [Full Text] [Related]
7. [Overview of MRI contrast media. The case of endorem].
Duroux M
Radiologe; 1995 Nov; 35(11 Suppl 2):S247-8. PubMed ID: 8588029
[No Abstract] [Full Text] [Related]
8. SPIO-MRI in the detection of hepatocellular carcinoma.
Araki T
J Gastroenterol; 2000; 35(11):874-6. PubMed ID: 11085500
[No Abstract] [Full Text] [Related]
9. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Takahashi M
J Comput Assist Tomogr; 1995; 19(4):665-7. PubMed ID: 7622710
[No Abstract] [Full Text] [Related]
10. [Differential diagnosis of focal liver lesions using contrast-enhanced MRI with SHU 555 A in comparison with unenhanced MRI and multidetector spiral-CT].
Jung G; Poll L; Cohnen M; Saleh A; Vogler H; Wettstein M; Willers R; Mödder U; Koch JA
Rofo; 2005 Nov; 177(11):1571-7. PubMed ID: 16302139
[TBL] [Abstract][Full Text] [Related]
11. Results of a multicenter phase II clinical trial with a susceptibility contrast medium for magnetic resonance imaging of the liver.
Balzer T; Carter EC; Shamsi K; Niendorf HP
Acad Radiol; 1996 Aug; 3 Suppl 2():S417-9. PubMed ID: 8796619
[No Abstract] [Full Text] [Related]
12. [Detection of liver tumors].
Rummeny EJ; Reimer P; Daldrup H; Peters PE
Radiologe; 1995 Nov; 35(11 Suppl 2):S252-8. PubMed ID: 8588031
[TBL] [Abstract][Full Text] [Related]
13. [Focal intrahepatic siderosis, diagnostic pitfall, iatrogenic image].
Arteaga C; Raillat A; Salamand P; Debonne JM; Bonnet D; Martet G; Veuillet MO; Battini-Nouzille A; Briant JF
J Radiol; 1998 Feb; 79(2):157-8. PubMed ID: 9757234
[No Abstract] [Full Text] [Related]
14. Ferucarbotran (Resovist): a new clinically approved RES-specific contrast agent for contrast-enhanced MRI of the liver: properties, clinical development, and applications.
Reimer P; Balzer T
Eur Radiol; 2003 Jun; 13(6):1266-76. PubMed ID: 12764641
[TBL] [Abstract][Full Text] [Related]
15. [MR contrast agent: resovist (SH U 555A)].
Nakajima H; Ichikawa T
Nihon Rinsho; 2001 Oct; 59 Suppl 6():328-32. PubMed ID: 11761967
[No Abstract] [Full Text] [Related]
16. Resovist for imaging of hepatocellular carcinoma in the cirrhotic liver.
Weishaupt D; Willmann JK; Lutz AM; Marincek B
Eur Radiol; 2004 Jan; 14 Suppl 1():C5-6. PubMed ID: 15113059
[No Abstract] [Full Text] [Related]
17. [Clinical application of AMI-25 (superparamagnetic iron oxide) for the MR imaging of hepatic tumors: a multicenter clinical phase III study].
Yoshikawa K; Sasaki Y; Ogawa N; Sakuma S
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Feb; 54(2):137-53. PubMed ID: 8121779
[TBL] [Abstract][Full Text] [Related]
18. [New super-paramagnetic iron particles for MRI. Phase II study of malignant liver tumors].
Daldrup HE; Reimer P; Rummeny EJ; Tombach B; Berns T; Balzer T; Schimpfky C; Peters PE
Radiologe; 1995 Aug; 35(8):486-93. PubMed ID: 7568792
[TBL] [Abstract][Full Text] [Related]
19. Hepatic tumors: detection and characterization at 1-T MR imaging enhanced with AMI-25.
Denys A; Arrive L; Servois V; Dubray B; Najmark D; Sibert A; Menu Y
Radiology; 1994 Dec; 193(3):665-9. PubMed ID: 7972805
[TBL] [Abstract][Full Text] [Related]
20. Double contrast MR imaging of hepatocellular carcinoma evaluating lesion detection and conspicuity.
Akinci D; Oto A; Besim A; Akhan O; Abbasoglu O; Batman F; Eryilmaz M
Acad Radiol; 2002 Aug; 9 Suppl 2():S466-7. PubMed ID: 12188310
[No Abstract] [Full Text] [Related]
[Next] [New Search]
